142 related articles for article (PubMed ID: 31353156)
1. Evolution of renal function and predictive value of serial renal assessments among patients with acute coronary syndrome: BIOMArCS study.
Brankovic M; Kardys I; van den Berg V; Oemrawsingh R; Asselbergs FW; van der Harst P; Hoefer IE; Liem A; Maas A; Ronner E; Schotborgh C; The SHK; Hoorn EJ; Boersma E; Akkerhuis KM;
Int J Cardiol; 2020 Jan; 299():12-19. PubMed ID: 31353156
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of β-trace protein and cystatin C for the prediction of mortality in non ST segment elevation acute coronary syndromes.
Manzano-Fernández S; López-Cuenca A; Januzzi JL; Parra-Pallares S; Mateo-Martínez A; Sánchez-Martínez M; Pérez-Berbel P; Orenes-Piñero E; Romero-Aniorte AI; Avilés-Plaza F; Valdés-Chavarri M; Marín F
Am J Cardiol; 2012 Nov; 110(9):1240-8. PubMed ID: 22818840
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Risk Prediction With the CKD-EPI and MDRD Equations in Non-ST-Segment Elevation Acute Coronary Syndrome.
Flores-Blanco PJ; López-Cuenca Á; Januzzi JL; Marín F; Sánchez-Martínez M; Quintana-Giner M; Romero-Aniorte AI; Valdés M; Manzano-Fernández S
Clin Cardiol; 2016 Sep; 39(9):507-15. PubMed ID: 27249221
[TBL] [Abstract][Full Text] [Related]
4. Cystatin C and estimated glomerular filtration rate as predictors for adverse outcome in patients with ST-elevation and non-ST-elevation acute coronary syndromes: results from the Platelet Inhibition and Patient Outcomes study.
Akerblom Å; Wallentin L; Siegbahn A; Becker RC; Budaj A; Buck K; Giannitsis E; Horrow J; Husted S; Katus HA; Steg PG; Storey RF; Åsenblad N; James SK
Clin Chem; 2012 Jan; 58(1):190-9. PubMed ID: 22126936
[TBL] [Abstract][Full Text] [Related]
5. Correlations of serum cystatin C and glomerular filtration rate with vascular lesions and severity in acute coronary syndrome.
Zhang J; Wu X; Gao P; Yan P
BMC Cardiovasc Disord; 2017 Jan; 17(1):47. PubMed ID: 28143410
[TBL] [Abstract][Full Text] [Related]
6. Impact of Serum Cystatin C-Based Glomerular Filtration Rate Estimates on Drug Dose Selection in Hospitalized Patients.
Peters BJ; Rule AD; Kashani KB; Lieske JC; Mara KC; Dierkhising RA; Barreto EF
Pharmacotherapy; 2018 Oct; 38(10):1068-1073. PubMed ID: 30120844
[TBL] [Abstract][Full Text] [Related]
7. Incremental value of cystatin C over conventional renal metrics for predicting clinical response and outcomes in cardiac resynchronization therapy: The BIOCRT study.
Chatterjee NA; Singh JP; Szymonifka J; Deaño RC; Thai WE; Wai B; Min JK; Januzzi JL; Truong QA
Int J Cardiol; 2016 Feb; 205():43-49. PubMed ID: 26710332
[TBL] [Abstract][Full Text] [Related]
8. Cystatin C- Versus Creatinine-Based Assessment of Renal Function and Prediction of Early Outcomes Among Patients With a Left Ventricular Assist Device.
Pinsino A; Mondellini GM; Royzman EA; Hoffman KL; D'Angelo D; Mabasa M; Gaudig A; Zuver AM; Masoumi A; Garan AR; Mohan S; Husain SA; Toma K; Faillace RT; Giles JT; Takeda K; Takayama H; Naka Y; Topkara VK; Demmer RT; Radhakrishnan J; Colombo PC; Yuzefpolskaya M
Circ Heart Fail; 2020 Jan; 13(1):e006326. PubMed ID: 31959016
[TBL] [Abstract][Full Text] [Related]
9. Beta-trace protein and cystatin c as predictors of major bleeding in non-ST-segment elevation acute coronary syndrome.
López-Cuenca Á; Manzano-Fernández S; Marín F; Parra-Pallares S; Navarro-Peñalver M; Montalban-Larrea S; Andreu-Cayuelas JM; Romero-Aniorte AI; Avilés-Plaza F; Valdés-Chavarri M; Januzzi JL
Circ J; 2013; 77(8):2088-96. PubMed ID: 23698027
[TBL] [Abstract][Full Text] [Related]
10. Quantification of Renal Function and Cardiovascular Mortality in Patients Admitted to the Emergency Department with Suspected Acute Coronary Syndromes.
Bahrmann P; Bertsch T; Giannitsis E; Christ M; Hofner B; Christenson R; Lindahl B; Mueller C
Clin Lab; 2017 Sep; 63(9):1457-1466. PubMed ID: 28879725
[TBL] [Abstract][Full Text] [Related]
11. Major bleeding risk prediction using Chronic Kidney Disease Epidemiology Collaboration and Modification of Diet in Renal Disease equations in acute coronary syndrome.
Flores-Blanco PJ; López-Cuenca Á; Januzzi JL; Marín F; Sánchez-Martínez M; Quintana-Giner M; Romero-Aniorte AI; Valdés M; Manzano-Fernández S
Eur J Clin Invest; 2015 Apr; 45(4):385-93. PubMed ID: 25661774
[TBL] [Abstract][Full Text] [Related]
12. Plasma cystatin C and neutrophil gelatinase-associated lipocalin in relation to coronary atherosclerosis on intravascular ultrasound and cardiovascular outcome: Impact of kidney function (ATHEROREMO-IVUS study).
Brankovic M; Akkerhuis KM; Buljubasic N; Cheng JM; Oemrawsingh RM; Garcia-Garcia HM; Regar E; Serruys PW; van Geuns RJ; Boersma E; Kardys I
Atherosclerosis; 2016 Nov; 254():20-27. PubMed ID: 27680774
[TBL] [Abstract][Full Text] [Related]
13. Estimating the glomerular filtration rate using serum cystatin C levels in patients with spinal cord injuries.
Erlandsen EJ; Hansen RM; Randers E; Petersen LE; Abrahamsen J; Johannesen IL
Spinal Cord; 2012 Oct; 50(10):778-83. PubMed ID: 22547045
[TBL] [Abstract][Full Text] [Related]
14. Increased cystatin C levels as a risk factor of cardiovascular events in patients with preserved estimated glomerular filtration rate after elective percutaneous coronary intervention with drug-eluting stents.
Sai E; Shimada K; Miyauchi K; Masaki Y; Kojima T; Miyazaki T; Kurata T; Ogita M; Tsuboi S; Yoshihara T; Miyazaki T; Ohsaka A; Daida H
Heart Vessels; 2016 May; 31(5):694-701. PubMed ID: 25863806
[TBL] [Abstract][Full Text] [Related]
15. The predictive value of different equations for estimation of glomerular filtration rate in patients with coronary artery disease - Results from the AtheroGene study.
Waldeyer C; Karakas M; Scheurle C; Ojeda F; Schnabel RB; Zeller T; Zengin E; Westermann D; Schrage B; Bickel C; Rupprecht HJ; Lackner KJ; Blankenberg S; Seiffert M; Sinning C
Int J Cardiol; 2016 Oct; 221():908-13. PubMed ID: 27441467
[TBL] [Abstract][Full Text] [Related]
16. Estimating renal function in children: a new GFR-model based on serum cystatin C and body cell mass.
Andersen TB
Dan Med J; 2012 Jul; 59(7):B4486. PubMed ID: 22759853
[TBL] [Abstract][Full Text] [Related]
17. Serum cystatin C is associated with kidney function but not with cardiovascular risk factors or subclinical atherosclerosis in patients with Systemic Lupus Erythematosus.
Garcia-Garcia P; Castejon R; Tutor-Ureta P; Silvestre RA; Mellor-Pita S; Jimenez-Ortiz C; Yebra-Bango M
Clin Rheumatol; 2017 Dec; 36(12):2709-2717. PubMed ID: 28914371
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of cystatin C for the identification of illness severity in adult patients in a mixed intensive care unit.
Dalcomune DM; Terrão J; Porto ML; Vasquez EC; Baldo MP; Pereira TM
Clin Biochem; 2016 Jul; 49(10-11):762-7. PubMed ID: 27087511
[TBL] [Abstract][Full Text] [Related]
19. Plasma cystatin C for prediction of 1-year cardiac events in Mediterranean patients with non-ST elevation acute coronary syndrome.
Taglieri N; Fernandez-Berges DJ; Koenig W; Consuegra-Sanchez L; Fernandez JM; Robles NR; Sánchez PL; Beiras AC; Orbe PM; Kaski JC;
Atherosclerosis; 2010 Mar; 209(1):300-5. PubMed ID: 19819453
[TBL] [Abstract][Full Text] [Related]
20. Creatinine versus cystatin C for renal function-based mortality prediction in an elderly cohort: The Northern Manhattan Study.
Willey JZ; Moon YP; Husain SA; Elkind MSV; Sacco RL; Wolf M; Cheung K; Wright CB; Mohan S
PLoS One; 2020; 15(1):e0226509. PubMed ID: 31940363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
